Septo-optic-pituitary dysplasia

Handbook of Clinical Neurology

Volumn 87, Issue , 2007, Pages 39-52

  Humphreys, Peter ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HESX1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN;

BRAIN; GENETICS; HUMAN; MULTIPLE MALFORMATION SYNDROME; PATHOLOGY; PRENATAL DEVELOPMENT; REVIEW; SEPTOOPTIC DYSPLASIA;

ABNORMALITIES, MULTIPLE; BRAIN; HOMEODOMAIN PROTEINS; HUMANS; SEPTO-OPTIC DYSPLASIA;

EID: 67649345468     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)87003-5     Document Type: Review

References (83)

1. Abernethy L.J., Quribi M.A., and Smith C.S. Normal MR appearances of the posterior pituitary in central diabetes insipidus associated with septo-optic dysplasia. Pediatr Radiol 27 (1997) 45-47
2. Aicardi J., and Goutieres F. The syndrome of absence of the septum pellucidum with porencephalies and other developmental defects. Neuropediatrics 12 (1981) 319-329
3. Antonini S.R., Grecco Filbo A.S., and Elias L.L. Hesx1 gene in midline cerebral defects. J Pediatr 139 (2001) 754
4. August G.P., Lippe B.M., Blethen S.L., et al. Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. J Pediatr 116 (1990) 899-903
5. Banker B.Q., and Larroche J.C. Periventricular leukomalacia of infancy. Arch Neurol 7 (1962) 386-410
6. Barkovich A.J., Fram E.K., and Norman D. Septo-optic dysplasia: MR imaging. Radiology 171 (1989) 189-192
7. Barkovich A.J., Gressens P., and Evrard P. Formation, maturation, and disorders of brain neocortex. Am J Neuroradiol 13 (1992) 423-446
8. Barkovich A.J., and Kjos B.O. Schizencephaly: correlation of clinical findings with MR characteristics. Am J Neuroradiol 13 (1992) 85-94
9. Barkovich A.J., and Norman D. Anomalies of the corpus callosum: correlations with further anomalies of the brain. Am J Neuroradiol 9 (1988) 493-501
10. Belhocine O., André C., Kalifa G., et al. Does asymptomatic septal agenesis exist? A review of 34 cases. Pediatr Radiol 35 (2005) 410-418
11. Benner J.D., Preslan M.W., Gratz E., et al. Septo-optic dysplasia in two siblings. Am J Ophthalmol 109 (1990) 632-637
12. Blethen S.L., and Weldon V.V. Hypopituitarism and septo-optic 'dysplasia' in first cousins. Am J Med Genet 21 (1985) 123-129
13. Bodensteiner J.B., and Schaefer G.B. Wide cavum septum pellucidum: a marker of disturbed brain development. Pediatr Neurol 6 (1990) 391-394
14. Brickman J.M., Clements M., Tyrell R., et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 128 (2001) 5189-5199
15. Brodsky M.C., Conte F.A., Taylor D., et al. Sudden death in septo-optic dysplasia. Report of 5 cases. Arch Ophthalmol 115 (1997) 66-70
16. Brodsky M.C., and Glasier C.M. Optic nerve hypoplasia: clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Arch Ophthalmol 111 (1993) 66-74
17. Cameron F.J., Khadilkar W., and Stanhope R. Pituitary dysfunction, morbidity and mortality with congenital midline malformation of the cerebrum. Eur J Pediatr 158 (1999) 97-102
18. Carvalho L.R., Woods K., Mendonca B.B., et al. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Invest 112 (2003) 1192-1201
19. Cohen R.N., Cohen L.E., Botero D., et al. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 88 (2003) 4832-4839
20. Costin G., and Murphree A.L. Hypothalamic-pituitary function in children with optic nerve hypoplasia. Am J Dis Child 139 (1985) 249-254
21. Coulter C.L., Leech R.W., Schaefer G.B., et al. Midline cerebral dysgenesis, dysfunction of the hypothalamic-pituitary axis, and fetal alcohol effects. Arch Neurol 50 (1993) 771-775
22. Coupland S.G., and Sarnat H.B. Visual and auditory evoked potential correlates of cerebral malformations. Brain Dev 12 (1990) 466-472
23. Dattani M.L., Martinez-Barbera J., Thomas P.Q., et al. Molecular genetics of septo-optic dysplasia. Horm Res 53 Suppl. 1 (2000) 26-33
24. Dattani M.T., Martinez-Barbera J.P., Thomas P.Q., et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19 (1998) 125-133
25. Dattani M.T., and Robinson I.C. HESX1 and septo-optic dysplasia. Rev Endocr Metab Disord 3 (2002) 289-300
26. De Morsier G. Etudes sur les dysraphies cranio-encéphaliques, III: agénésie du septum lucidum avec malformation du tractus optique: la dysplasie septo-optique. Schweiz Arch Neurol Neurochir Psychiatr 77 (1956) 267-292
27. Dominguez R., Vila-Coro A.A., Slopis J.M., et al. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 145 (1991) 688-695
28. Fitz C.R. Holoprosencephaly and septo-optic dysplasia. Neuroimaging Clin North Am 4 (1994) 263-281
29. Forest M.G. Adrenal function tests. In: Ranke M.B. (Ed). Diagnostics of Endocrine Function in Children and Adolescents. 3rd edn. (2003), S Karger, Basel 372-426
30. Geffner M.E. Hypopituitarism in childhood. Cancer Control 9 (2002) 212-222
31. Groenveld M., Pohl K.R., Espezel H., and Jan J.E. The septum pellucidum and spatial ability of children with optic nerve hypoplasia. Dev Med Child Neurol 36 (1994) 191-197
32. Gunduz K., Gunalp I., and Saatci I. Septo-optic dysplasia associated with bilateral complex microphthalmos. Ophthalmic Genet 17 (1996) 109-113
33. Hanna C.E., Krainz P.L., Sheels M.R., et al. Detection of congenital hypopituitary hypothyroidism: ten-year experience in the Northwest Regional Screening Program. J Pediatr 109 (1986) 959-964
34. Hellstrom A., Wiklund L.M., and Svensson E. The clinical and morphologic spectrum of optic nerve hypoplasia. J AAPOS 3 (1999) 212-220
35. Hoyt W.F., Kaplan S.L., Grumbach M.M., et al. Septo-optic dysplasia and pituitary dwarfism. Lancet 1 (1970) 893-894
36. Humphreys P., Rosen G.D., Press D.M., et al. Freezing lesions of the developing rat brain: a model for cerebrocortical microgyria. J Neuropath Exp Neurol 50 (1991) 145-160
37. Kaufman L.M., Miller M.T., and Mafee M.F. Magnetic resonance imaging of pituitary stalk hypoplasia: a discrete midline anomaly associated with endocrine abnormalities in septo-optic dysplasia. Arch Ophthalmol 107 (1989) 1485-1489
38. Kletter G.B., and Kelch R.P. Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79 (1994) 331-334
39. Kuban K.C., Teele R.L., and Wallman J. Septo-optic-dysplasia-schizencephaly: radiographic and clinical features. Pediatr Radiol 19 (1989) 145-150
40. Lepinard C., Coutant R., Boussion F., et al. Prenatal diagnosis of absence of the septum pellucidum associated with septo-optic dysplasia. Ultrasound Obstet Gynecol 25 (2005) 73-75
41. Levine L.M., Bhatti M.T., and Mancuso A.A. Septo-optic dysplasia with olfactory tract and bulb hypoplasia. J AAPOS 5 (2001) 398-399
42. Lubinsky M.S. Hypothesis: septo-optic dysplasia is a vascular disruption sequence. Am J Med Genet 69 (1997) 235-236
43. Lubinsky M.S. Association of prenatal vascular disruptions with decreased maternal age. Am J Med Genet 69 (1997) 237-239
44. McMahon C.L., and Braddock S.R. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. Teratology 64 (2001) 83-86
45. Machinis K., Pantel J., Netchine I., et al. Syndromic short stature in patients with a germline mutation in the Lim homeobox LHX4. Am J Hum Genet 69 (2001) 961-968
46. Manor R.S., and Korczyn A.D. Retinal red-free light photogtraphy in two congenital conditions. Ophthalmologica 173 (1976) 119-127
47. Margalith D., Jan J.E., McCormick A.Q., et al. Clinical spectrum of congenital optic nerve hypoplasia: review of 51 patients. Dev Med Child Neurol 26 (1984) 311-322
48. Margalith D., Tze W.J., and Jan J.E. Congenital optic nerve hypoplasia with hypothalamic-pituitary dysplasia: a review of 16 cases. Am J Dis Child 139 (1985) 361-366
49. Masera N., Grant D.B., Stanhope R., et al. Diabetes insipidus with impaired osmotic regulation in septo-optic dysplasia and agenesis of the corpus callosum. Arch Dis Child 70 (1994) 51-53
50. Michaud J., Mizrahi E.M., and Urich H. Agenesis of the vermis with fusion of the cerebellar hemispheres, septo-optic dysplasia and associated anomalies. Acta Neuropathol (Berl) 56 (1982) 161-166
51. Miller M.A., Innes W.C., and Enloe L.J. Performance on a four-choice search task following septal lesions in rats. Physiol Psychol 5 (1977) 433-439
52. Miller S.P., Shevell M.I., Patenaude Y., et al. Septo-optic dysplasia plus: a spectrum of malformations of cortical development. Neurology 54 (2000) 1701-1703
53. Mitchell L.A., Thomas P.Q., Zacharin M.R., et al. Ectopic posterior pituitary lobe and periventricular heterotopia: cerebral malformations with the same underlying mechanism?. Am J Neuroradiol 23 (2002) 1475-1481
54. Morishima A., and Aranoff G.S. Syndrome of septo-optic-pituitary dysplasia: the clinical spectrum. Brain Dev 8 (1986) 233-239
55. Müller F., and O'Rahilly R. The human brain at stage 16, including the initial evagination of the neurohypophysis. Anat Embryol 179 (1989) 551-569
56. Nanduri V.R., and Stanhope R. Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?. Eur J Endocrinol 140 (1999) 48-50
57. Nuri Sener R. Septo-optic dysplasia associated with cerebral cortical dysplasia (cortico-septo-optic dysplasia). J Neuroradiol 23 (1996) 245-247
58. Orrico A., Galli L., Zappella M., et al. Septo-optic dysplasia with digital anomalies associated with maternal multidrug use during pregnancy. Eur J Neurol 9 (2002) 679-682
59. Oster S.F., Deiner M., Birgbauer E., et al. Ganglion cell axon pathfinding in the retina and optic nerve. Semin Cell Dev Biol 15 (2004) 125-136
60. Ouvrier R., and Billson F. Optic nerve hypoplasia: a review. J Child Neurol 1 (1986) 181-188
61. Parks J.S., Brown M.R., Hurley D.L., et al. Heritable disorders of pituitary development. J Clin Endocrinol Metab 84 (1999) 4362-4370
62. Patel H., Tze W.J., Crichton J.U., et al. Optic nerve hypoplasia with hypopituitarism: septo-optic dysplasia with hypopituitarism. Am J Dis Child 129 (1975) 175-180
63. Rainbow L.A., Reest S.A., Shaikh M.G., et al. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin Endocrinol 62 (2005) 163-168
64. Rakic P. Mode of cell migration to the superficial layers of fetal monkey neocortex. J Comp Neurol 145 (1972) 61-84
65. Rakic P., and Yakovlev P.I. Development of the corpus callosum and cavum septi in man. J Comp Neurol 132 (1968) 45-72
66. Ranke M.B. Diagnosis of growth hormone deficiency and growth hormone stimulation tests. In: Ranke M.B. (Ed). Diagnostics of Endocrine Function in Children and Adolescents. 3rd edn. (2003), S Karger, Basel 107-128
67. Reeves D.L. Congenital absence of the septum pellucidum: a case diagnosed encephalographically and associated with congenital amaurosis. Bull Johns Hopkins Hosp 69 (1941) 61-71
68. Roessmann U., Velasco M.E., Small E.J., et al. Neuropathology of 'septo-optic dysplasia' (de Morsier syndrome) with immunohistochemical studies of the hypothalamus and pituitary gland. J Neuropathol Exp Neurol 46 (1987) 597-608
69. Sarnat H.B., and Flores-Sarnat L. Neuropathologic research strategies in holoprosencephaly. J Child Neurol 16 (2001) 918-931
70. Schuelke M., Krude H., Finckh B., et al. Septo-optic dysplasia associated with a new mitochondrial cytochrome b mutation. Ann Neurol 51 (2002) 388-392
71. Siatkowski R.M., Sanchez J.C., Andrade R., et al. The clinical, neuroradiographic, and endocrinologic profile of patients with bilateral optic nerve hypoplasia. Ophthalmology 104 (1997) 493-496
72. Skarf B., and Hoyt C.S. Optic nerve hypoplasia in children: association with anomalies of the endocrine and CNS. Arch Ophthalmol 102 (1984) 62-67
73. Stanhope R., De Luca F., Delemarre-Van de Waal H.A., et al. International Workshop on Management of Puberty for Optimum Auxological Results (2001). Multiple pituitary hormone deficiency: management of puberty for optimal auxological results. J Pediatr Endocrinol Metab 14 (2001) 1009-1014
74. Stevens C.A., and Dobyns W.B. Septo-optic dysplasia and amniotic bands: further evidence for a vascular pathogenesis. Am J Med Genet 125A (2004) 12-16
75. Swaab D.F. Neuropathology of the human hypothalamus and adjacent brain structures. The Human Hypothalamus: Basic and Clinical Aspects. In: Aminoff M.J., Boller F., and Swaab D.F. (Eds). Handbook of Clinical Neurology vol 80. (2005), Elsevier, Amsterdam 30-34
76. Tajima T., Hattorri T., Nakajima T., et al. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone insufficiency in a Japanese patient. J Clin Endocrinol Metab 88 (2003) 45-50
77. Thomas P.Q., Dattani M.T., Brickman J.M., et al. Heterozygous HESX1 mutations associated with isolated pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 10 (2001) 39-45
78. Triulzi F., Scotti G., de Natale B., et al. Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics 93 (1994) 409-416
79. Van Tijn D.A., de Vijlder J.J.M., Verbeeten B., et al. Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 90 (2005) 3350-3359
80. Volpe J.J. Neurology of the Newborn. 4th edn. (2001), WB Saunders, Philadelphia 307-323
81. Wales J.K., and Quarrell O.W. Evidence for possible mendelian inheritance of septo-optic dysplasia. Acta Paediatr 85 (1996) 391-392
82. Williams J., Brodsky M.C., Griebel M., et al. Septo-optic dysplasia: the clinical insignificance of an absent septum pellucidum. Dev Med Child Neurol 35 (1993) 490-501
83. Zeki S.M., Hollman A.S., and Dutton G.N. Neuroradiological features of patients with optic nerve hypoplasia. J Pediatr Ophthalmol Strabismus 29 (1992) 107-112